Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47


Skin-homing CD4+ Foxp3+ T cells exert Th2-like function after staphylococcal superantigen stimulation in atopic dermatitis patients.

Lin YT, Wang CT, Chao PS, Lee JH, Wang LC, Yu HH, Yang YH, Chiang BL.

Clin Exp Allergy. 2011 Apr;41(4):516-25. doi: 10.1111/j.1365-2222.2010.03681.x. Epub 2011 Jan 24.


Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.

Pangault C, Amé-Thomas P, Ruminy P, Rossille D, Caron G, Baia M, De Vos J, Roussel M, Monvoisin C, Lamy T, Tilly H, Gaulard P, Tarte K, Fest T.

Leukemia. 2010 Dec;24(12):2080-9. doi: 10.1038/leu.2010.223. Epub 2010 Oct 14.


Implications of the tumor microenvironment on survival and disease response in follicular lymphoma.

Gribben JG.

Curr Opin Oncol. 2010 Sep;22(5):424-30. doi: 10.1097/CCO.0b013e32833d5938. Review.


Prognostic factors in follicular lymphoma.

Relander T, Johnson NA, Farinha P, Connors JM, Sehn LH, Gascoyne RD.

J Clin Oncol. 2010 Jun 10;28(17):2902-13. doi: 10.1200/JCO.2009.26.1693. Epub 2010 Apr 12. Review. Erratum in: J Clin Oncol. 2010 Oct 20;28(30):4664.


Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment.

Clear AJ, Lee AM, Calaminici M, Ramsay AG, Morris KJ, Hallam S, Kelly G, Macdougall F, Lister TA, Gribben JG.

Blood. 2010 Jun 17;115(24):5053-6. doi: 10.1182/blood-2009-11-253260. Epub 2010 Apr 7.


Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity.

Aymeric L, Apetoh L, Ghiringhelli F, Tesniere A, Martins I, Kroemer G, Smyth MJ, Zitvogel L.

Cancer Res. 2010 Feb 1;70(3):855-8. doi: 10.1158/0008-5472.CAN-09-3566. Epub 2010 Jan 19. Review.


A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages.

Wahlin BE, Aggarwal M, Montes-Moreno S, Gonzalez LF, Roncador G, Sanchez-Verde L, Christensson B, Sander B, Kimby E.

Clin Cancer Res. 2010 Jan 15;16(2):637-50. doi: 10.1158/1078-0432.CCR-09-2487. Epub 2010 Jan 12.


CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.

Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, O'Farrelly C, Tubridy N, Mills KH.

J Immunol. 2009 Dec 1;183(11):7602-10. doi: 10.4049/jimmunol.0901881. Epub 2009 Nov 16.


Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness.

Hilchey SP, Kobie JJ, Cochran MR, Secor-Socha S, Wang JC, Hyrien O, Burack WR, Mosmann TR, Quataert SA, Bernstein SH.

J Immunol. 2009 Nov 15;183(10):6157-66. doi: 10.4049/jimmunol.0900475. Epub 2009 Oct 28.


Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy.

Ramsay AG, Clear AJ, Kelly G, Fatah R, Matthews J, Macdougall F, Lister TA, Lee AM, Calaminici M, Gribben JG.

Blood. 2009 Nov 19;114(21):4713-20. doi: 10.1182/blood-2009-04-217687. Epub 2009 Sep 28.


Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors.

Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E, Perfettini JL, Schlemmer F, Tasdemir E, Uhl M, Génin P, Civas A, Ryffel B, Kanellopoulos J, Tschopp J, André F, Lidereau R, McLaughlin NM, Haynes NM, Smyth MJ, Kroemer G, Zitvogel L.

Nat Med. 2009 Oct;15(10):1170-8. doi: 10.1038/nm.2028. Epub 2009 Sep 20.


Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation.

Johnston RJ, Poholek AC, DiToro D, Yusuf I, Eto D, Barnett B, Dent AL, Craft J, Crotty S.

Science. 2009 Aug 21;325(5943):1006-10. doi: 10.1126/science.1175870. Epub 2009 Jul 16.


Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma.

Yang ZZ, Novak AJ, Ziesmer SC, Witzig TE, Ansell SM.

Cancer Res. 2009 Jul 1;69(13):5522-30. doi: 10.1158/0008-5472.CAN-09-0266. Epub 2009 Jun 9.


Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments.

Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, Huang E, Finlayson E, Simeone D, Welling TH, Chang A, Coukos G, Liu R, Zou W.

Blood. 2009 Aug 6;114(6):1141-9. doi: 10.1182/blood-2009-03-208249. Epub 2009 May 21.


Follicular helper T cells: lineage and location.

Fazilleau N, Mark L, McHeyzer-Williams LJ, McHeyzer-Williams MG.

Immunity. 2009 Mar 20;30(3):324-35. doi: 10.1016/j.immuni.2009.03.003. Review.


High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.

Carreras J, Lopez-Guillermo A, Roncador G, Villamor N, Colomo L, Martinez A, Hamoudi R, Howat WJ, Montserrat E, Campo E.

J Clin Oncol. 2009 Mar 20;27(9):1470-6. doi: 10.1200/JCO.2008.18.0513. Epub 2009 Feb 17.


T helper cytokine patterns: defined subsets, random expression, and external modulation.

Mosmann TR, Kobie JJ, Lee FE, Quataert SA.

Immunol Res. 2009 Dec;45(2-3):173-84. doi: 10.1007/s12026-009-8098-5. Epub 2009 Feb 6. Review.


Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab.

Hilchey SP, Hyrien O, Mosmann TR, Livingstone AM, Friedberg JW, Young F, Fisher RI, Kelleher RJ Jr, Bankert RB, Bernstein SH.

Blood. 2009 Apr 16;113(16):3809-12. doi: 10.1182/blood-2008-10-185280. Epub 2009 Feb 4.


Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery.

Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, Bover L, Qin FX, Gilliet M, Liu YJ.

Immunity. 2008 Jun;28(6):870-80. doi: 10.1016/j.immuni.2008.03.018. Epub 2008 May 29.


T-cell quality in memory and protection: implications for vaccine design.

Seder RA, Darrah PA, Roederer M.

Nat Rev Immunol. 2008 Apr;8(4):247-58. doi: 10.1038/nri2274. Epub 2008 Mar 7. Review. Erratum in: Nat Rev Immunol. 2008 Jun;8(6):486.

Items per page

Supplemental Content

Write to the Help Desk